Patients with obesity defined by a body mass index above 30 kg/m2 tended to have higher clusterin levels (median 58.9 μg/mL vs. median 51.1 μg/mL in non-obese patients, p = 0.066) (Figure 3B). Here, CLU is linked to obesity disorder.